Daniel T Claiborne

Daniel T Claiborne

Harvard University

H-index: 14

North America-United States

About Daniel T Claiborne

Daniel T Claiborne, With an exceptional h-index of 14 and a recent h-index of 12 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Virology, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope

Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer

The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition

An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression

Of mice, or men: TLR4 signaling in HIV pathogenesis

Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis

Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT mice

Innate immune reconstitution in humanized bone marrow-liver-thymus (HuBLT) mice governs adaptive cellular immune function and responses to HIV-1 infection

Daniel T Claiborne Information

University

Position

Ragon Institute of MGH, MIT and Harvard

Citations(all)

984

Citations(since 2020)

526

Cited By

666

hIndex(all)

14

hIndex(since 2020)

12

i10Index(all)

16

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Daniel T Claiborne Skills & Research Interests

Virology

Immunology

Top articles of Daniel T Claiborne

A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope

Journal of Virology

2024/2/27

Daniel T Claiborne
Daniel T Claiborne

H-Index: 10

Eric Rosenberg
Eric Rosenberg

H-Index: 11

Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer

Nature Cancer

2023/10

Daniel T Claiborne
Daniel T Claiborne

H-Index: 10

The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition

Cancer Research Communications

2023/7/11

Daniel T Claiborne
Daniel T Claiborne

H-Index: 10

An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression

Cancer discovery

2023/7/7

Of mice, or men: TLR4 signaling in HIV pathogenesis

2023/5/2

Daniel T Claiborne
Daniel T Claiborne

H-Index: 10

Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis

Cancer cell

2023/4/10

Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT mice

European journal of immunology

2022/3

Daniel T Claiborne
Daniel T Claiborne

H-Index: 10

Alejandro Balazs
Alejandro Balazs

H-Index: 25

Innate immune reconstitution in humanized bone marrow-liver-thymus (HuBLT) mice governs adaptive cellular immune function and responses to HIV-1 infection

Frontiers in Immunology

2021/5/26

Daniel T Claiborne
Daniel T Claiborne

H-Index: 10

Meredith Phelps
Meredith Phelps

H-Index: 2

Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivo

Nature medicine

2020/11

Better Viral Control despite Higher CD4+ T Cell Activation during Acute HIV-1 Infection in Zambian Women Is Linked to the Sex Hormone Estradiol

Journal of Virology

2020/7/30

HIV-1 variants are archived throughout infection and persist in the reservoir

PLoS pathogens

2020/6/3

Daniel T Claiborne
Daniel T Claiborne

H-Index: 10

Eric Hunter
Eric Hunter

H-Index: 38

See List of Professors in Daniel T Claiborne University(Harvard University)